Precio de cierre
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
40,54 CNY | +3,66 % | +12,49 % | -21,36 % |
Resumen de negocios
Número de empleados: 1 961
Ventas por actividad
CNY en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Drug
98,4
%
| 2 342 | 98,6 % | 2 417 | 98,4 % | +3,17 % |
Promotional Services
0,9
%
| 19 | 0,8 % | 22 | 0,9 % | +15,37 % |
Factory Rental
0,7
%
| 14 | 0,6 % | 16 | 0,7 % | +11,48 % |
Others
0,0
%
| 0 | 0,0 % | 1 | 0,0 % | +126,44 % |
Ventas por región
CNY en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
China
100,0
%
| 2 376 | 100,0 % | 2 455 | 100,0 % | +3,32 % |
Abroad
0,0
%
| 0 | 0,0 % | 1 | 0,0 % | +126,04 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Jia Tong
CEO | Chief Executive Officer | 46 | 01/01/03 |
Lie Ming Ding
CEO | Chief Executive Officer | 60 | 07/01/03 |
Jian Xun Fan
DFI | Director of Finance/CFO | 53 | 01/01/16 |
Jiang Wan
COO | Chief Operating Officer | 56 | 01/04/11 |
Jia Bing Wang
CTO | Chief Tech/Sci/R&D Officer | 60 | 28/02/16 |
Jian Hao Shen
IRC | Investor Relations Contact | - | - |
Ling Xi Wu
SEC | Corporate Secretary | 41 | 24/09/20 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Lie Ming Ding
CEO | Chief Executive Officer | 60 | 07/01/03 |
Wei Wang
BRD | Director/Board Member | 57 | 22/11/19 |
Jia Tong
CEO | Chief Executive Officer | 46 | 01/01/03 |
Jiang Wan
COO | Chief Operating Officer | 56 | 01/04/11 |
Fei Wu
BRD | Director/Board Member | 47 | 27/11/17 |
Jian Xun Fan
DFI | Director of Finance/CFO | 53 | 01/01/16 |
Tian Xu
BRD | Director/Board Member | 62 | 17/10/22 |
Xin Qi Huang
BRD | Director/Board Member | 53 | 22/01/21 |
Jia Jia Xiao
BRD | Director/Board Member | 41 | 17/10/22 |
Rong Wang
BRD | Director/Board Member | 61 | 27/12/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 418 485 885 | 215 716 338 ( 51,55 %) | 0 | 51,55 % |
Participaciones
Nombre | Acciones | % | Valoración |
---|---|---|---|
C4 THERAPEUTICS, INC. 8.12% | 5 567 928 | 8.12% | 45 489 972 $ |
Información de la empresa
Betta Pharmaceuticals Co., Ltd.
355 Xingzhong Road Yuhang Economic & Tech Dev Zone
311100, Hangzhou
+
http://www.bettapharma.comSector
Ventas por actividad
Ventas por región
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-21,36 % | 2341,22 M | |
+5,31 % | 70,44 mil M | |
+10,97 % | 8939,13 M | |
-16,83 % | 4750,81 M | |
+43,48 % | 4497,76 M | |
+3,20 % | 3845,87 M | |
+18,82 % | 2375,28 M | |
-29,67 % | 2196,26 M | |
+8,38 % | 1963,71 M | |
+3,90 % | 1645,88 M |
- Bolsa de valores
- Acciones
- Acción 300558
- Empresa Betta Pharmaceuticals Co., Ltd.